247 related articles for article (PubMed ID: 24044644)
1. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Verma P; Gupta RN; Jha AK; Pandey R
Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
Mishra V; Jain NK
Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
[TBL] [Abstract][Full Text] [Related]
3. Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation.
Pisal PB; Joshi MA; Padamwar MN; Patil SS; Pokharkar VB
Int J Pharm; 2014 Jan; 461(1-2):82-8. PubMed ID: 24291077
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
5. Promising complexes of acetazolamide for topical ocular administration.
Granero GE; Longhi MR
Expert Opin Drug Deliv; 2010 Aug; 7(8):943-53. PubMed ID: 20565335
[TBL] [Abstract][Full Text] [Related]
6. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
Rathod LV; Kapadia R; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
[TBL] [Abstract][Full Text] [Related]
7. An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration.
Palma SD; Tartara LI; Quinteros D; Allemandi DA; Longhi MR; Granero GE
J Control Release; 2009 Aug; 138(1):24-31. PubMed ID: 19426769
[TBL] [Abstract][Full Text] [Related]
8. Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostructures as drug delivery system.
Tártara LI; Quinteros DA; Saino V; Allemandi DA; Palma SD
J Ocul Pharmacol Ther; 2012 Apr; 28(2):102-9. PubMed ID: 22060001
[TBL] [Abstract][Full Text] [Related]
9. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
10. Electrosprayed 4-carboxybenzenesulfonamide-chitosan microspheres for acetazolamide delivery.
Suvannasara P; Siralertmukul K; Muangsin N
Int J Biol Macromol; 2014 Mar; 64():240-6. PubMed ID: 24360896
[TBL] [Abstract][Full Text] [Related]
11. Novel cubosome based system for ocular delivery of acetazolamide.
Teba HE; Khalil IA; El Sorogy HM
Drug Deliv; 2021 Dec; 28(1):2177-2186. PubMed ID: 34662264
[TBL] [Abstract][Full Text] [Related]
12. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
[TBL] [Abstract][Full Text] [Related]
13. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
Aggarwal D; Garg A; Kaur IP
J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
[TBL] [Abstract][Full Text] [Related]
14. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
15. Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide.
Quinteros DA; Ferreira LM; Schaffazick SR; Palma SD; Allemandi DA; Cruz L
J Pharm Sci; 2016 Oct; 105(10):3183-3190. PubMed ID: 27519647
[TBL] [Abstract][Full Text] [Related]
16. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
18. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor.
Aggarwal D; Pal D; Mitra AK; Kaur IP
Int J Pharm; 2007 Jun; 338(1-2):21-6. PubMed ID: 17300885
[TBL] [Abstract][Full Text] [Related]
19. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
20. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
Gandhi A; Jana S; Sen KK
Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
